{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T21:49:32Z","timestamp":1789681772032,"version":"4.0.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009045","name":"Uniwersytet Jagiello\u0144ski Collegium Medicum","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009045","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","onlinecjc.ca","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.cjca.2019.09.004","type":"journal-article","created":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T11:18:05Z","timestamp":1568719085000},"page":"500-508","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Bleeding Tolerance Among Patients With Atrial Fibrillation on Oral Anticoagulation"],"prefix":"10.1016","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3617-0285","authenticated-orcid":false,"given":"Gabriela","family":"Rusin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Konieczy\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Bijak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8641-4658","authenticated-orcid":false,"given":"Lien","family":"Desteghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hein","family":"Heidbuchel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2189-0498","authenticated-orcid":false,"given":"Krzysztof Piotr","family":"Malinowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anetta","family":"Undas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2019.09.004_bib1","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1160\/TH16-11-0876","article-title":"Stroke prevention in atrial fibrillation: past, present and future. Comparing the guidelines and practical decision-making","volume":"117","author":"Lip","year":"2017","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.cjca.2019.09.004_bib2","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","article-title":"Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation","volume":"146","author":"Hart","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cjca.2019.09.004_bib3","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2019.09.004_bib4","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1056\/NEJMoa1007432","article-title":"Apixaban in patients with atrial fibrillation","volume":"364","author":"Connolly","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2019.09.004_bib5","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2019.09.004_bib6","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2019.09.004_bib7","first-page":"1371","article-title":"2018 Focused update of the Canadian Cardiovascular Society guidelines for the management of atrial fibrillation","volume":"34","author":"Andrade","year":"2018","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2019.09.004_bib8","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/ejcts\/ezw313","article-title":"2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"50","author":"Kirchhof","year":"2016","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.cjca.2019.09.004_bib9","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s40256-015-0123-6","article-title":"Bleeding risk, management and outcome in patients receiving non-VKA oral anticoagulants (NOACs)","volume":"15","author":"Werth","year":"2015","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.cjca.2019.09.004_bib10","doi-asserted-by":"crossref","first-page":"565","DOI":"10.2165\/00003088-200847090-00002","article-title":"Pharmacogenetics of oral anticoagulants: a basis for dose individualization","volume":"47","author":"Stehle","year":"2008","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.cjca.2019.09.004_bib11","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/CRD.0000000000000088","article-title":"Non-vitamin K antagonist oral anticoagulants and antiplatelet therapy for stroke prevention in patients with atrial fibrillation: a meta-analysis of randomized controlled trials","volume":"24","author":"Kumar","year":"2016","journal-title":"Cardiol Rev"},{"key":"10.1016\/j.cjca.2019.09.004_bib12","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.pcad.2015.07.003","article-title":"Oral anticoagulant therapy in atrial fibrillation patients at high stroke and bleeding risk","volume":"58","author":"Potpara","year":"2015","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.cjca.2019.09.004_bib13","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1161\/01.STR.0000141933.75462.c2","article-title":"Combined anticoagulant-antiplatelet use and major bleeding events in elderly atrial fibrillation patients","volume":"35","author":"Shireman","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.cjca.2019.09.004_bib14","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.ahj.2013.12.014","article-title":"Physician practices regarding contraindications to oral anticoagulation in atrial fibrillation: findings from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry","volume":"167","author":"O'Brien","year":"2014","journal-title":"Am Heart J"},{"key":"10.1016\/j.cjca.2019.09.004_bib15","doi-asserted-by":"crossref","first-page":"805","DOI":"10.20452\/pamw.4161","article-title":"Towards a better education of patients with atrial fibrillation: the initiative of the Polish Cardiac Society","volume":"127","author":"Trusz-Gluza","year":"2017","journal-title":"Pol Arch Intern Med"},{"key":"10.1016\/j.cjca.2019.09.004_bib16","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/europace\/euy054","article-title":"The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: executive summary","volume":"20","author":"Steffel","year":"2018","journal-title":"Europace"},{"key":"10.1016\/j.cjca.2019.09.004_bib17","first-page":"465","article-title":"Evaluation of patients' attitudes towards stroke prevention and bleeding risk in atrial fibrillation","volume":"111","author":"LaHaye","year":"2014","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.cjca.2019.09.004_bib18","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1136\/bmj.323.7323.1218","article-title":"Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: observational study","volume":"323","author":"Devereaux","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/j.cjca.2019.09.004_bib19","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.ijcard.2016.08.303","article-title":"Knowledge gaps in patients with atrial fibrillation revealed by a new validated knowledge questionnaire","volume":"223","author":"Desteghe","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cjca.2019.09.004_bib20","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.5603\/KP.a2018.0069","article-title":"Differences in knowledge among patients with atrial fibrillation receiving non-vitamin K antagonist oral anticoagulants and vitamin K antagonists","volume":"76","author":"Konieczy\u0144ska","year":"2018","journal-title":"Kardiol Pol"},{"key":"10.1016\/j.cjca.2019.09.004_bib21","doi-asserted-by":"crossref","first-page":"437","DOI":"10.5603\/KP.a2019.0036","article-title":"Polish regional differences in patient knowledge on atrial fibrillation and its management as well as in patterns of oral anticoagulant prescription","volume":"77","author":"Janion-Sadowska","year":"2019","journal-title":"Kardiol Pol"},{"key":"10.1016\/j.cjca.2019.09.004_bib22","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.thromres.2015.05.028","article-title":"Denser plasma clot formation and impaired fibrinolysis in paroxysmal and persistent atrial fibrillation while on sinus rhythm: association with thrombin generation, endothelial injury and platelet activation","volume":"136","author":"Drabik","year":"2015","journal-title":"Thromb Res"},{"key":"10.1016\/j.cjca.2019.09.004_bib23","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","volume":"3","author":"Schulman","year":"2005","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.cjca.2019.09.004_bib24","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1093\/eurheartj\/ehs167","article-title":"A\u00a0clinical decision aid for the selection of antithrombotic therapy for the prevention of stroke due to atrial fibrillation","volume":"33","author":"LaHaye","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cjca.2019.09.004_bib25","first-page":"474","article-title":"Comparison of health-related quality of life among patients using novel oral anticoagulants or warfarin for non-valvular atrial fibrillation","volume":"16","author":"Balc\u0131","year":"2016","journal-title":"Anatol J Cardiol"},{"key":"10.1016\/j.cjca.2019.09.004_bib26","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1046\/j.1365-2796.2002.01009.x","article-title":"Atrial fibrillation or flutter and stroke: a Danish population-based study of the effectiveness of oral anticoagulation in clinical practice","volume":"252","author":"Frost","year":"2002","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.cjca.2019.09.004_bib27","doi-asserted-by":"crossref","first-page":"274","DOI":"10.20452\/pamw.4320","article-title":"District versus academic hospitals: differences in the clinical characteristics of patients with atrial fibrillation without valvular heart disease treated with oral anticoagulants","volume":"128","author":"Bednarski","year":"2018","journal-title":"Pol Arch Intern Med"},{"key":"10.1016\/j.cjca.2019.09.004_bib28","doi-asserted-by":"crossref","first-page":"625","DOI":"10.5603\/KP.a2017.0241","article-title":"Evaluation of the recommended prevention of thrombosis in hospitalised patients with atrial fibrillation and high thromboembolism risk","volume":"76","author":"Gorczyca","year":"2018","journal-title":"Kardiol Pol"},{"key":"10.1016\/j.cjca.2019.09.004_bib29","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-018242","article-title":"Association between subjective risk perception and objective risk estimation in patients with atrial fibrillation: a cross-sectional study","volume":"7","author":"Zweiker","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.cjca.2019.09.004_bib30","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1160\/TH16-12-0961","article-title":"Cessation of oral anticoagulation is an important risk factor for stroke and mortality in atrial fibrillation patients","volume":"117","author":"Rivera-Caravaca","year":"2017","journal-title":"Thromb Haemost"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X19312607?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X19312607?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:42:26Z","timestamp":1760107346000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X19312607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S0828282X19312607"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2019.09.004","relation":{},"ISSN":["0828-282X"],"issn-type":[{"value":"0828-282X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bleeding Tolerance Among Patients With Atrial Fibrillation on Oral Anticoagulation","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cjca.2019.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}